{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:22:58Z","timestamp":1790104978617,"version":"4.0.1"},"reference-count":95,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Liquid biopsy provides a non-invasive approach for cancer detection. It examines tumor-associated components in blood and other body fluids, including circulating tumor cells (CTCs), circulating tumor DNA (ctDNA), and extracellular vesicles (EVs, including exosomes). This technology is transforming cancer diagnosis, prognosis, and therapy monitoring. This review summarizes recent advancements in liquid biopsy technologies, particularly focusing on circulating tumor components such as ctDNA, CTCs, and EVs. This review emphasizes the role of liquid biopsy in the early detection of drug resistance and therapeutic response monitoring. A primary emphasis is on how liquid biopsy detects various forms of drug resistance. It evaluates treatment efficacy, monitors alterations in tumor genomics over time, and assists in customizing therapy for people. We also discuss the integration of liquid biopsy with innovative technologies such as artificial intelligence and big data. The objective is to provide practical guidance for the future development of precision oncology.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1795789","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:25:51Z","timestamp":1775107551000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Liquid biopsy in cancer drug resistance: real-time monitoring, mechanistic insights, and translational applications"],"prefix":"10.3389","volume":"17","author":[{"given":"Yiyang","family":"Li","sequence":"first","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benliang","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianshuai","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leqi","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanyu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Colorectal Surgery, Shanghai Changhai Hospital","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.42731","article-title":"Advancements and applications of liquid biopsies in oncology: a narrative review","volume":"15","author":"Noor","year":"2023","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2025.100290","article-title":"The prospects and limitations of liquid biopsy utilization for clinical practice in Taiwan","volume":"7","author":"Li","year":"2025","journal-title":"J Liq Biopsy"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15153804","article-title":"The current landscape of glioblastoma biomarkers in body fluids","volume":"15","author":"Zanganeh","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1612674","article-title":"Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer","volume":"376","author":"Mok","year":"2017","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2017.04.003","article-title":"Plasma ctDNA analysis for detection of the EGFR T790M mutation in patients with advanced non-small cell lung cancer","volume":"12","author":"Jenkins","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2024.100146","article-title":"Liquid biopsy into the clinics: current evidence and future perspectives","volume":"4","author":"Boukovala","year":"2024","journal-title":"J Liq Biopsy"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1185013","article-title":"Genome-wide studies in prostate cancer poised liquid biopsy as a molecular discovery tool","volume":"13","author":"Lo","year":"2023","journal-title":"Front Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2024.100151","article-title":"Unlocking the promise of liquid biopsies in precision oncology","volume":"3","author":"Pando-Caciano","year":"2024","journal-title":"J Liq Biopsy"},{"key":"B9","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12943-019-1074\u20133","article-title":"The role of exosomal PD-L1 in tumor progression and immunotherapy","volume":"18","author":"Xie","year":"2019","journal-title":"Mol Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26115013","article-title":"Liquid biopsy: the challenges of a revolutionary approach in oncology","volume":"26","author":"Coppola","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2023.117757","article-title":"Liquid biopsy in lung cancer","volume":"554","author":"Li","year":"2023","journal-title":"Clin Chim Acta"},{"key":"B12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12943-022-01505-z","article-title":"Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring","volume":"21","author":"Li","year":"2022","journal-title":"Mol Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1177\/2516865720904052","article-title":"Liquid biopsy: the unique test for chasing the genetics of solid tumors","volume":"13","author":"Aghamir","year":"2020","journal-title":"Epigenet Insights"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052504","article-title":"Heterogeneous manifestations of epithelial-mesenchymal plasticity of circulating tumor cells in breast cancer patients","volume":"22","author":"Tashireva","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010127","article-title":"High-throughput label-free isolation of heterogeneous circulating tumor cells and CTC clusters from non-small-cell lung cancer patients","volume":"12","author":"Zeinali","year":"2020","journal-title":"Cancers (Basel)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-021-00559-x","article-title":"Commercial ctDNA assays for minimal residual disease detection of solid tumors","volume":"25","author":"Chen","year":"2021","journal-title":"Mol Diagn Ther"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.pccm.2023.08.005","article-title":"Liquid biopsy for early detection of lung cancer","volume":"1","author":"Bibikova","year":"2023","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1177\/20503121221077838","article-title":"Role of circulating tumor DNA and circulating tumor cells in breast cancer: history and updates","volume":"10","author":"Chedid","year":"2022","journal-title":"SAGE Open Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-021-00795\u20135","article-title":"Liquid biopsy for prognosis and treatment in metastatic colorectal cancer: circulating tumor cells vs circulating tumor DNA","volume":"16","author":"Patelli","year":"2021","journal-title":"Target Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-24\u2013828","article-title":"The latest advances in liquid biopsy for lung cancer-a narrative review","volume":"13","author":"She","year":"2024","journal-title":"Transl Lung Cancer Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3346-5_7","article-title":"Liquid biopsy in bladder cancer","volume":"2695","author":"Cui","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14184504","article-title":"Feasibility of leukemia-derived exosome enrichment and co-isolated dsDNA sequencing in acute myeloid leukemia patients: a proof of concept for new leukemia biomarkers detection","volume":"14","author":"Bernardi","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0000000000002414","article-title":"Current understanding of therapeutic and diagnostic applications of exosomes in pancreatic cancer","volume":"54","author":"Shakerian","year":"2025","journal-title":"Pancreas"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1344705","article-title":"Exosomes: a promising avenue for cancer diagnosis beyond treatment","volume":"12","author":"Wang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3724\/SP.J.1123.2020.01014","article-title":"Preparation of 4-mercaptophenylboronic acid functionalized two-dimensional molybdenum disulfide nanocomposite and its specific enrichment for N-glycopeptide","volume":"38","author":"Zhang","year":"2020","journal-title":"Se Pu"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1424081","article-title":"The therapeutic potential of exosomes in immunotherapy","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.11817\/j.issn.1672-7347.2024.230595","article-title":"Role of exosomes in regulating ferroptosis of tumor cells","volume":"49","author":"Xu","year":"2024","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA118.000644","article-title":"The impact of oncogenic EGFRvIII on the proteome of extracellular vesicles released from glioblastoma cells","volume":"17","author":"Choi","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0295-2","article-title":"Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41392-020-00359-5","article-title":"Exosome-mediated metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112236","article-title":"Clinical applications of liquid biopsy in non-small cell lung cancer patients: current status and recent advances in clinical practice","volume":"10","author":"Park","year":"2021","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25168594","article-title":"Liquid biopsy in the clinical management of cancers","volume":"25","author":"Ho","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.03.012","article-title":"Liquid biopsy-based biomarkers of treatment response and resistance","volume":"37","author":"Kilgour","year":"2020","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.08.053","article-title":"Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (EORTC Lung Cancer Group 1613 APPLE): a phase 2 randomized clinical trial","volume":"34","author":"Remon","year":"2023","journal-title":"Ann Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30444-7","article-title":"Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial","volume":"21","author":"Turner","year":"2020","journal-title":"Lancet Oncol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3346-5_9","article-title":"Diagnosis, monitoring, and prognosis of liquid biopsy in cancer immunotherapy","volume":"2695","author":"Kong","year":"2023","journal-title":"Methods Mol Biol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.564","article-title":"Liquid biopsy for human cancer: cancer screening, monitoring, and treatment","volume":"5","author":"Wang","year":"2024","journal-title":"MedComm (2020)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0392-8","article-title":"Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response","volume":"560","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2561","article-title":"Circulating tumor cells and response to chemotherapy in metastatic breast cancer: SWOG S0500","volume":"32","author":"Smerage","year":"2014","journal-title":"J Clin Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.241030","article-title":"Update on liquid biopsy","volume":"315","author":"Mayerhoefer","year":"2025","journal-title":"Radiology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14030732","article-title":"Exosomal proteins and lipids as potential biomarkers for lung cancer diagnosis, prognosis, and treatment","volume":"14","author":"Hsu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s12032-023-02128\u20130","article-title":"Liquid biopsy in ovarian cancer: advantages and limitations for prognosis and diagnosis","volume":"40","author":"Karimi","year":"2023","journal-title":"Med Oncol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2707205","article-title":"Exosomes in liquid biopsy: a nanotool for postradiotherapy cancer monitoring","volume":"27","author":"Shi","year":"2022","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03254-6","article-title":"ctDNA-based molecular residual disease and survival in resectable colorectal cancer: interim results from the CIRCULATE-Japan GALAXY study","volume":"30","author":"Nakamura","year":"2024","journal-title":"Nat Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/13685538.2021.1944085","article-title":"Liquid biopsy in prostate cancer: current status and future challenges of clinical application","volume":"24","author":"Wang","year":"2021","journal-title":"Aging Male"},{"key":"B46","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.cca.2020.06.047","article-title":"Liquid biopsy in ovarian cancer","volume":"510","author":"Bhardwaj","year":"2020","journal-title":"Clin Chim Acta"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241914713","article-title":"Clinical significance of extracellular vesicles in prostate and renal cancer","volume":"24","author":"Chen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0000000000000672","article-title":"Recent advances in blood-based liquid biopsy approaches in prostate cancer","volume":"29","author":"Cani","year":"2023","journal-title":"Cancer J"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1055\/a-1124\u20137225","article-title":"Liquid biopsy in breast cancer","volume":"80","author":"Banys-Paluchowski","year":"2020","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1055\/s-0044\u20131801753","article-title":"Liquid biopsy and colorectal cancer","volume":"13","author":"Aggarwal","year":"2024","journal-title":"South Asian J Cancer"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2024.2408744","article-title":"Liquid biopsy for early cancer detection: technological revolutions and clinical dilemma","volume":"24","author":"Fu","year":"2024","journal-title":"Expert Rev Mol Diagn"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.70119","article-title":"Discrepancy between liquid biopsy and tumor next-generation sequencing due to low tumor fraction in a patient with lung adenocarcinoma","volume":"16","author":"Baker","year":"2024","journal-title":"Cureus"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.plabm.2024.e00446","article-title":"Liquid biopsy in cancer management: integrating diagnostics and clinical applications","volume":"43","author":"Pandey","year":"2025","journal-title":"Pract Lab Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-022-01534\u20138","article-title":"Integration of liquid biopsy and pharmacogenomics for precision therapy of EGFR mutant and resistant lung cancers","volume":"21","author":"Kolesar","year":"2022","journal-title":"Mol Cancer"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.78321","article-title":"Exosomes in genitourinary cancers: emerging mediators of drug resistance and promising biomarkers","volume":"19","author":"Lu","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.33386","article-title":"The role of exosomes in liquid biopsy for cancer diagnosis and prognosis prediction","volume":"148","author":"Li","year":"2021","journal-title":"Int J Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2024.100144","article-title":"Exosomes-based liquid biopsy: an effective approach for drugs and therapeutics resistance screening in cancer","volume":"4","author":"Nyahatkar","year":"2024","journal-title":"J Liq Biopsy"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2023.100134","article-title":"Exosomes in liquid biopsy and oncology: nanotechnological interplay and the quest to overcome cancer drug resistance","volume":"3","author":"Mukerjee","year":"2024","journal-title":"J Liq Biopsy"},{"key":"B59","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13045-020-00987-y","article-title":"Isolation and characterization of exosomes for cancer research","volume":"13","author":"Zhu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12935-021-01943\u20137","article-title":"Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma","volume":"21","author":"Weinman","year":"2021","journal-title":"Cancer Cell Int"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2021.01.001","article-title":"The biology, function, and applications of exosomes in cancer","volume":"11","author":"Liu","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207766","article-title":"Genetic heterogeneity of single circulating tumour cells in colorectal carcinoma","volume":"21","author":"Hamid","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1021\/acsami.4c06272","article-title":"Engineered leukocyte biomimetic colorimetric sensor enables high-efficient detection of tumor cells based on bioorthogonal chemistry","volume":"16","author":"Li","year":"2024","journal-title":"ACS Appl Mater Interfaces"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102417","article-title":"Liquid biopsy as a tool for KRAS\/NRAS\/BRAF baseline testing in metastatic colorectal cancer","volume":"48","author":"Kourie","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B65","first-page":"1","article-title":"Plasma-based comprehensive genomic profiling DNA assays for non-small cell lung cancer: a health technology assessment","volume":"24","year":"2024","journal-title":"Ont Health Technol Assess Ser"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1221773","article-title":"Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis","volume":"13","author":"Najim","year":"2023","journal-title":"Front Oncol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40580-024-00428\u20133","article-title":"SERS biosensors for liquid biopsy towards cancer diagnosis by detection of various circulating biomarkers: current progress and perspectives","volume":"11","author":"Lyu","year":"2024","journal-title":"Nano Converg"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01531-y","article-title":"Optical nanomaterial-based detection of biomarkers in liquid biopsy","volume":"17","author":"Kim","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn1886","article-title":"Surpassing sensitivity limits in liquid biopsy","volume":"383","author":"Moser","year":"2024","journal-title":"Science"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43650","article-title":"The emerging role of liquid biopsies in revolutionising cancer diagnosis and therapy","volume":"15","author":"Shegekar","year":"2023","journal-title":"Cureus"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002776","article-title":"Liquid biopsies for early detection and monitoring of cancer: advances, challenges, and future directions","volume":"87","author":"Qureshi","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s42003-024-06368-2","article-title":"CRISPR\/Cas13a-based supersensitive circulating tumor DNA assay for detecting EGFR mutations in plasma","volume":"7","author":"Wang","year":"2024","journal-title":"Commun Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13184640","article-title":"CRISPR\/Cas13-based platforms for a potential next-generation diagnosis of colorectal cancer through exosomes micro-RNA detection: a review","volume":"13","author":"Dur\u00e1n-Vinet","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1080\/10408363.2023.2230290","article-title":"Pre-analytical conditions and implementation of quality control steps in liquid biopsy analysis","volume":"60","author":"Ntzifa","year":"2023","journal-title":"Crit Rev Clin Lab Sci"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103112","article-title":"International liquid biopsy standardization alliance white paper","volume":"156","author":"Connors","year":"2020","journal-title":"Crit Rev Oncol Hematol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jlb.2023.100006","article-title":"Moving liquid biopsies to the front-line of lung cancer treatment decisions","volume":"1","author":"Raez","year":"2023","journal-title":"J Liq Biopsy"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1200\/OP.22.00405","article-title":"Impact of simultaneous circulating tumor DNA and tissue genotyping in the workup of stage IV lung adenocarcinoma on quality of care in an academic community medical center","volume":"19","author":"Maity","year":"2023","journal-title":"JCO Oncol Pract"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1101\/mcs.a006201","article-title":"Incidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient","volume":"8","author":"Nkosi","year":"2022","journal-title":"Cold Spring Harb Mol Case Stud"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2021.02.010","article-title":"Beyond standard practice in liquid biopsy: selective venous sampling","volume":"32","author":"Damascelli","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-025-01628\u20134","article-title":"Predicting response to patients with gastric cancer via a dynamic-aware model with longitudinal liquid biopsy data","volume":"28","author":"Chen","year":"2025","journal-title":"Gastric Cancer"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.110183","article-title":"AutoCancer as an automated multimodal framework for early cancer detection","volume":"27","author":"Liu","year":"2024","journal-title":"iScience"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-02048\u20132","article-title":"Integrative analysis of multi-omics data for liquid biopsy","volume":"128","author":"Chen","year":"2023","journal-title":"Br J Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41420-020-00373\u20130","article-title":"Liquid biopsies and cancer omics","volume":"6","author":"Amelio","year":"2020","journal-title":"Cell Death Discov"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkad777","article-title":"cfOmics: a cell-free multi-omics database for diseases","volume":"52","author":"Li","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-022-01768\u20139","article-title":"Circulating tumour cells in the -omics era: how far are we from achieving the \u2018singularity\u2019","volume":"127","author":"Visal","year":"2022","journal-title":"Br J Cancer"},{"key":"B86","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1007\/s10238-025-01752\u20136","article-title":"Innovative technologies and their clinical prospects for early lung cancer screening","volume":"25","author":"Deng","year":"2025","journal-title":"Clin Exp Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.21037\/jtd-24\u20131058","article-title":"Precise diagnosis and prognosis assessment of Malignant lung nodules: a narrative review","volume":"16","author":"Wen","year":"2024","journal-title":"J Thorac Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/cyt.13396","article-title":"Exploring the potential of multiomics liquid biopsy testing in the clinical setting of lung cancer","volume":"35","author":"Gottardo","year":"2024","journal-title":"Cytopathology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17193165","article-title":"Artificial intelligence-enhanced liquid biopsy and radiomics in early-stage lung cancer detection: a precision oncology paradigm","volume":"17","author":"Cherukuri","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B90","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/s41419-020-03189-z","article-title":"Exosomes and breast cancer drug resistance","volume":"11","author":"Dong","year":"2020","journal-title":"Cell Death Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.06.010","article-title":"Exosomal lncRNAs and circRNAs in lung cancer: emerging regulators and potential therapeutic targets","volume":"9","author":"Li","year":"2024","journal-title":"Non-coding RNA Res"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1331215","article-title":"Metabolomic biomarkers in liquid biopsy: accurate cancer diagnosis and prognosis monitoring","volume":"14","author":"Wang","year":"2024","journal-title":"Front Oncol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11070630","article-title":"Personalized therapy and liquid biopsy-a focus on colorectal cancer","volume":"11","author":"Christou","year":"2021","journal-title":"J Pers Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1292861","article-title":"Integration of liquid biopsy and immunotherapy: opening a new era in colorectal cancer treatment","volume":"14","author":"Yao","year":"2023","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2019.05.004","article-title":"Personalized medicine: from diagnostic to adaptive","volume":"45","author":"Braig","year":"2022","journal-title":"BioMed J"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1795789\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T05:25:53Z","timestamp":1775107553000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1795789\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":95,"alternative-id":["10.3389\/fimmu.2026.1795789"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1795789","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"article-number":"1795789"}}